When people act, they repeatedly have to make value-based decisions about the further course of actions. For example, when driving on the highway, they must decide whether to overtake other cars by changing lanes to arrive at their destination quicker; concurrently, they are required to stay on their momentary lane by controlling the steering wheel. Embodied choice models predict that concurrent action execution modulates value-based decisions. Here, we examined whether value-based decisions are influenced by a change of action costs and/or cognitive interference between concurrent actions and decision making. In a novel, computerized multilane tracking task paradigm, participants (N = 50) controlled a cursor moving on one of three horizontal lanes. During tracking (concurrent action), participants had to switch to other lanes to avoid obstacles or collect rewards (value-based decisions). The action costs associated with a lane switch depended on the cursor position relative to the currently tracked lane, and this relationship varied between conditions. Results showed that value-based lane switching decisions were biased by the cursor state. While this influence was partly attributed to minimizing action costs, a considerable part of the influence could be attributed to cognitive interference. Our findings provide further evidence for embodied choice models, showing that both cognitive interference as well as action costs bias value-based decisions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.actpsy.2021.103449 | DOI Listing |
Public Health Pract (Oxf)
June 2025
Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Background: Shared decision-making (SDM) incorporates evidence, patient values, and preferences into medical decision-making. SDM and decision aids might promote health professional engagement and patient knowledge of tobacco cessation therapy, improving usage and results. The SDM facilitates talks that lead to better-informed judgements that align with patients' priorities, unlike individual decision-making.
View Article and Find Full Text PDFFront Public Health
January 2025
Department of Social Medicine and Epidemiology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Introduction: Due to the rapid aging of the global population, new approaches are required to improve the quality of life of older people and to reduce healthcare system expenditures. One of the approaches that can be used is value-based healthcare. This article describes a value-based solution for older people who have suffered a myocardial infarction.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Center for Value-Based Care Research, Cleveland Clinic, Cleveland, Ohio.
Importance: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease and is projected to become the leading indication for liver transplant (LT) in the US. Understanding its clinical burden can help to identify opportunities for prevention and treatment.
Objective: To project the burden of MASLD in US adults from 2020 to 2050.
J Bone Joint Surg Am
November 2024
Department of Orthopaedic Surgery, Harvard Medical School, Boston Shoulder Institute, Massachusetts General Hospital, Boston, Massachusetts.
Background: Rotator cuff repair (RCR) is a frequently performed outpatient orthopaedic surgery, with substantial financial implications for health-care systems. Time-driven activity-based costing (TDABC) is a method for nuanced cost analysis and is a valuable tool for strategic health-care decision-making. The aim of this study was to apply the TDABC methodology to RCR procedures to identify specific avenues to optimize cost-efficiency within the health-care system in 2 critical areas: (1) the reduction of variability in the episode duration, and (2) the standardization of suture anchor acquisition costs.
View Article and Find Full Text PDFJ Immunother Precis Oncol
February 2025
Medical Affairs Division, Roche Products India Pvt Ltd, New Delhi, India.
Biologic factors limiting responsiveness to matched targeted therapies include genomic heterogeneity and complexity. Advanced tumors with unique molecular profiles can be studied by comprehensive genomic profiling (CGP) and enhance patient outcomes using principles of precision medicine. The clinical utility of CGP across all cancer types and different therapeutic interventions using overall survival (OS) and progression-free survival (PFS) data was studied in this systematic literature review.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!